| Exhibit No. | | | Description | | | Filed with this Form 10-K | | | Incorporation by Reference | | | | | | | | |
| Exhibit No. | | | Description | | | Filed with this Form 10-K | | | Form | | | Filing Date | | | Exhibit No. | | |
| 10.9* | | | Charles River Laboratories International, Inc. Non-Employee Directors Deferral Plan dated April 5, 2016 | | | | | | 10-Q | | | May 4, 2016 | | | 10.1 | | |
| 10.10* | | | Charles River Laboratories, Inc. Executive Life Insurance/Supplemental Retirement Income Plan | | | | | | 10-K | | | March 9, 2005 | | | 10.23 | | |
| 10.11* | | | Amended and Restated Employment Agreement by and between James C. Foster and Charles River International, Inc., dated May 18, 2021 | | | | | | 8-K | | | May 18, 2021 | | | 99.1 | | |
| 10.12* | | | Amendment to the Amended and Restated Employment Agreement by and between James C. Foster and Charles River International, Inc., dated May 20, 2025 | | | | | | 10-Q | | | August 6, 2025 | | | 10.1 | | |
| 10.13* | | | Amendment No. 2 to the Amended and Restated Employment Agreement by and between James C. Foster and Charles River International, Inc., dated January 6, 2026 | | | X | | | | | | | | | | | |
| 10.14* | | | Executive Incentive Compensation Program effective January 1, 2021 | | | | | | 10-Q | | | May 4, 2021 | | | 10.2 | | |
| 10.15† | | | Charles River Laboratories amended and restated Deferred Compensation Plan, as amended | | | | | | 10-K | | | February 19, 2025 | | | 10.13 | | |
| 10.16 | | | Tenth Amended and Restated Credit Agreement, dated as of December 13, 2024, among Charles River Laboratories International, Inc., the Subsidiary Borrowers party thereto, the lenders party thereto, JPMorgan Chase Bank, N.A., as administrative agent, and the other agents party thereto | | | | | | 8-K | | | December 13, 2024 | | | 10.1 | | |
| 10.17* | | | Charles River Laboratories International, Inc. Restricted Stock Unit Award, dated December 25, 2021 granted to Joseph W. LaPlume | | | | | | 8-K | | | December 27, 2021 | | | 10.1 | | |
| 10.18* | | | Charles River Laboratories International, Inc. Performance Share Unit Award, dated December 25, 2021 granted to Joseph W. LaPlume | | | | | | 8-K | | | December 27, 2021 | | | 10.2 | | |
| 10.19 | | | Cooperation Agreement, by and among the Company and Elliott Investment Management L.P., Elliott Associates, L.P. and Elliott International, L.P., dated as of May 6, 2025 | | | | | | 8-K | | | May 7, 2025 | | | 10.1 | | |
| 10.20* | | | Letter Agreement by and between Charles River Laboratories International, Inc. and Birgit Girshick, dated as of January 6, 2026 | | | X | | | | | | | | | | | |
| 19 | | | Insider Trading Policy | | | | | | 10-K | | | February 14, 2024 | | | 19 | | |
| 21.1 | | | Subsidiaries of Charles River Laboratories International, Inc. | | | X | | | | | | | | | | | |
| 23.1 | | | Consent of PricewaterhouseCoopers LLP | | | X | | | | | | | | | | | |
| 31.1 | | | Rule 13a-14(a)/15d-14(a) Certification of Chief Executive Officer | | | X | | | | | | | | | | | |
| 31.2 | | | Rule 13a-14(a)/15d-14(a) Certification of Chief Financial Officer | | | X | | | | | | | | | | | |
| 32.1 | | | Section 1350 Certification of the Chief Executive Officer and Chief Financial Officer | | | X | | | | | | | | | | | |
| 97 | | | Financial Statement Compensation Recoupment Policy | | | | | | 10-K | | | February 14, 2024 | | | 97 | | |
| 101.INS | | | eXtensible Business Reporting Language (XBRL) Instance Document - the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document | | | X | | | | | | | | | | | |
| 101.SCH | | | XBRL Taxonomy Extension Schema Document | | | X | | | | | | | | | | | |
| 101.CAL | | | XBRL Taxonomy Calculation Linkbase Document | | | X | | | | | | | | | | | |
| 101.DEF | | | XBRL Taxonomy Definition Linkbase Document | | | X | | | | | | | | | | | |
| 101.LAB | | | XBRL Taxonomy Label Linkbase Document | | | X | | | | | | | | | | | |
| 101.PRE | | | XBRL Taxonomy Presentation Linkbase Document | | | X | | | | | | | | | | | |
| 104 | | | Cover Page Interactive Data File (embedded within the Inline XBRL document) | | | | | | | | | | | | | | |
| * Management contract or compensatory plan, contract or arrangement. | | | | | | | | | | | | | | | | | |
| † Certain information in this exhibit was omitted by means of redacting a portion of the text and replacing it with [***] | | | | | | | | | | | | | | | | | |